Corrigendum to “Factors influencing the efficacy of nebulized colistimethate sodium in the treatment of severe lung infection caused by carbapenem-resistant gram-negative bacteria” [International Journal of Infectious Diseases. 2026 Jun; 167:108588]
- DOI
- 10.1016/j.ijid.2026.108801
- Published
- 2026-08
- Container
- International Journal of Infectious Diseases
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ijid.2026.108801,
title = {Corrigendum to “Factors influencing the efficacy of nebulized colistimethate sodium in the treatment of severe lung infection caused by carbapenem-resistant gram-negative bacteria” [International Journal of Infectious Diseases. 2026 Jun; 167:108588]},
author = {Yao Fu and Ran Li and Genhua Mu and Chuji Cheng and Mingjing Zhao and Yan Gu and Chunmei Zhang and Yang Tao and Yuanyuan Yi and Hongyang Xu and Dan Li and Genjie Wang and Shukun Chai and Bing Dai and Yanjing Xu and Shuling Deng and Lin Dou and Zhiyu Wang and Yongli Zhang and Zhancheng Gao and Dong Zhang},
year = {2026},
journal = {International Journal of Infectious Diseases},
doi = {10.1016/j.ijid.2026.108801},
url = {https://doi.org/10.1016/j.ijid.2026.108801}
}RIS
TY - JOUR TI - Corrigendum to “Factors influencing the efficacy of nebulized colistimethate sodium in the treatment of severe lung infection caused by carbapenem-resistant gram-negative bacteria” [International Journal of Infectious Diseases. 2026 Jun; 167:108588] AU - Yao Fu AU - Ran Li AU - Genhua Mu AU - Chuji Cheng AU - Mingjing Zhao AU - Yan Gu AU - Chunmei Zhang AU - Yang Tao AU - Yuanyuan Yi AU - Hongyang Xu AU - Dan Li AU - Genjie Wang AU - Shukun Chai AU - Bing Dai AU - Yanjing Xu AU - Shuling Deng AU - Lin Dou AU - Zhiyu Wang AU - Yongli Zhang AU - Zhancheng Gao AU - Dong Zhang PY - 2026 JO - International Journal of Infectious Diseases DO - 10.1016/j.ijid.2026.108801 UR - https://doi.org/10.1016/j.ijid.2026.108801 ER -
APA
Fu, Y., Li, R., Mu, G., Cheng, C., Zhao, M., Gu, Y., Zhang, C., Tao, Y., Yi, Y., Xu, H., Li, D., Wang, G., Chai, S., Dai, B., Xu, Y., Deng, S., Dou, L., Wang, Z., Zhang, Y., Gao, Z., & Zhang, D. (2026). Corrigendum to “Factors influencing the efficacy of nebulized colistimethate sodium in the treatment of severe lung infection caused by carbapenem-resistant gram-negative bacteria” [International Journal of Infectious Diseases. 2026 Jun; 167:108588]. International Journal of Infectious Diseases. https://doi.org/10.1016/j.ijid.2026.108801
Source records
- crossref · retrieved 2026-09-26T05:23:02.857Z